Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Buxbaum

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Pathology Annual|January 1, 1982
The kidney in lymphoplasmacytic disordersG R Gallo, H D Feiner, J N Buxbaum
Human Genetics|September 1, 1992
Transthyretin Pro 36 associated with familial amyloidotic polyneuropathy in an Ashkenazic Jewish kindredD R Jacobson, C J Rosenthal, J N Buxbaum
The American Journal of the Medical Sciences|January 1, 1992
Oncogene alterations in rat colon tumors induced by N-methyl-N-nitrosoureaR J Alexander, J N Buxbaum, R F Raicht
The American Journal of the Medical Sciences|April 1, 1991
Enhanced expression of oncogene-encoded mRNA in a rat model of colon cancerR J Alexander, J N Buxbaum, R F Raicht
Human Mutation|January 1, 1994
Transthyretin VAL107, a new variant associated with familial cardiac and neuropathic amyloidosisD R Jacobson, M A Gertz, J N Buxbaum
Neuroscience|June 24, 2014
Silencing of murine transthyretin and retinol binding protein genes has distinct and shared behavioral and neuropathologic effectsJ N Buxbaum, A J Roberts, A Adame, et al.
Neuroscience|April 13, 2025
Corrigendum to "Silencing of murine transthyretin and retinol binding protein genes have distinct and shared behavioral and neuropathologic effects" [Neuroscience 275 (2014) 352-364]J N Buxbaum, A J Roberts, A Adame, et al.
The American Journal of Medicine|November 1, 1979
Amyloidosis of the AL type. Clinical, morphologic and biochemical aspects of the response to therapy with alkylating agents and prednisoneJ N Buxbaum, M E Hurley, J Chuba, et al.
Somatic Cell and Molecular Genetics|January 1, 1984
Isolation of highly malignant Thy-1-positive revertants from cultured cloned Thy-1-negative lymphoma cells of low tumorigenicityR S Basch, E Lakow, M Teng, et al.
Journal of Cellular Physiology|June 1, 1981
Demonstration of a hematopoietic stem cell antigen (SC-1) on a murine lymphoma and isolation of variants lacking the antigenR S Basch, T Panagiotatos, J W Berman, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Pathology Annual|January 1, 1982
The kidney in lymphoplasmacytic disordersG R Gallo, H D Feiner, J N Buxbaum
Human Genetics|September 1, 1992
Transthyretin Pro 36 associated with familial amyloidotic polyneuropathy in an Ashkenazic Jewish kindredD R Jacobson, C J Rosenthal, J N Buxbaum
The American Journal of the Medical Sciences|January 1, 1992
Oncogene alterations in rat colon tumors induced by N-methyl-N-nitrosoureaR J Alexander, J N Buxbaum, R F Raicht
The American Journal of the Medical Sciences|April 1, 1991
Enhanced expression of oncogene-encoded mRNA in a rat model of colon cancerR J Alexander, J N Buxbaum, R F Raicht
Human Mutation|January 1, 1994
Transthyretin VAL107, a new variant associated with familial cardiac and neuropathic amyloidosisD R Jacobson, M A Gertz, J N Buxbaum
Neuroscience|June 24, 2014
Silencing of murine transthyretin and retinol binding protein genes has distinct and shared behavioral and neuropathologic effectsJ N Buxbaum, A J Roberts, A Adame, et al.
Neuroscience|April 13, 2025
Corrigendum to "Silencing of murine transthyretin and retinol binding protein genes have distinct and shared behavioral and neuropathologic effects" [Neuroscience 275 (2014) 352-364]J N Buxbaum, A J Roberts, A Adame, et al.
The American Journal of Medicine|November 1, 1979
Amyloidosis of the AL type. Clinical, morphologic and biochemical aspects of the response to therapy with alkylating agents and prednisoneJ N Buxbaum, M E Hurley, J Chuba, et al.
Somatic Cell and Molecular Genetics|January 1, 1984
Isolation of highly malignant Thy-1-positive revertants from cultured cloned Thy-1-negative lymphoma cells of low tumorigenicityR S Basch, E Lakow, M Teng, et al.
Journal of Cellular Physiology|June 1, 1981
Demonstration of a hematopoietic stem cell antigen (SC-1) on a murine lymphoma and isolation of variants lacking the antigenR S Basch, T Panagiotatos, J W Berman, et al.
Pageof 5